Pauls Matthew — SEC insider filings
SEC reporting owner CIK 1573429. 30 insider filings on record with FilingPulse; latest filed 2026-10-06.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2020-09-15 to 2026-10-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 8 filings — 155,750 shares, $240,244 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 146,997 shares, $1,055,032 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 36.
- Largest priced transaction: sale of 5,937 shares @ $71.55 ($424,797) in SOLENO THERAPEUTICS INC, filed 2025-03-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Savara Inc (SVRA) | CHIEF EXECUTIVE OFFICER, Director | 18 | 11 legs · 155,750 sh · $240,244 | 2 legs · 138,702 sh · $576,729 | 20 |
| SOLENO THERAPEUTICS INC (SLNO) | Director | 5 | — | 1 leg · 5,937 sh · $424,797 | 7 |
| Pelthos Therapeutics Inc. (PTHS) | Director | 6 | — | 5 legs · 2,358 sh · $53,507 | 8 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | Director | 1 | — | — | 1 |
Insider filings — Pauls Matthew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-06 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 786 @ $21 | EDGAR |
| 2026-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 692 @ $26.00 · Sale (S): 94 @ $27.36 | EDGAR |
| 2026-07-01 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Disposition to issuer (D): 10,491 · Disposition to issuer (D): 9,063 (derivative) | EDGAR |
| 2026-04-06 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 415 @ $20.52 · Sale (S): 371 @ $21.36 | EDGAR |
| 2026-04-01 | 4/A | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 25,478 @ $0 | EDGAR |
| 2025-12-16 | 4 | Savara Inc (SVRA) | Tax withholding (F): 195,705 @ $6.92 · Gift (G): 128,995 @ $0 | EDGAR |
| 2025-12-12 | 4 | Pelthos Therapeutics Inc. (PTHS) | Option exercise (M): 8,493 @ $0 · Option exercise (M): 2,123 @ $0 · Gift (G): 9,542 @ $0 · Option exercise (M): 8,493 (derivative) @ $0 · Option exercise (M): 2,123 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Savara Inc (SVRA) | Gift (G): 23,629 @ $0 | EDGAR |
| 2025-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 25,478 (derivative) · Grant/award (A): 77,640 (derivative) | EDGAR |
| 2025-06-09 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 3,991 @ $0 | EDGAR |
| 2025-03-31 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Option exercise (M): 5,937 @ $4.60 · Sale (S): 5,937 @ $71.55 · Option exercise (M): 5,937 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Savara Inc (SVRA) | Grant/award (A): 400,000 @ $0 · Tax withholding (F): 92,593 @ $3.21 · Sale (S): 54,702 @ $3.31 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 6,500 @ $0 | EDGAR |
| 2023-12-29 | 4 | Savara Inc (SVRA) | Sale (S): 84,000 @ $4.71 · Gift (G): 19,000 @ $0 | EDGAR |
| 2023-12-15 | 4 | Savara Inc (SVRA) | Tax withholding (F): 109,680 @ $4.45 · Grant/award (A): 450,000 @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2023-08-16 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-12-15 | 4 | Savara Inc (SVRA) | Grant/award (A): 325,000 @ $0 · Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | Savara Inc (SVRA) | Tax withholding (F): 62,318 @ $1.24 | EDGAR |
| 2021-12-14 | 4 | Savara Inc (SVRA) | Grant/award (A): 400,000 @ $0 · Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2021-12-08 | 4 | Savara Inc (SVRA) | Purchase (P): 6,500 @ $1.06 | EDGAR |
| 2021-12-02 | 4 | Savara Inc (SVRA) | Purchase (P): 10,000 @ $1.10 | EDGAR |
| 2021-11-22 | 4 | Savara Inc (SVRA) | Purchase (P): 10,000 @ $1.10 · Purchase (P): 10,000 @ $1.11 · Purchase (P): 2,150 @ $1.06 | EDGAR |
| 2021-08-18 | 4 | Savara Inc (SVRA) | Purchase (P): 15,000 @ $1.18 · Purchase (P): 11,900 @ $1.19 | EDGAR |
| 2021-05-24 | 4 | Savara Inc (SVRA) | Purchase (P): 10,000 @ $1.63 | EDGAR |
| 2021-04-19 | 4 | Savara Inc (SVRA) | Purchase (P): 27,400 @ $1.82 | EDGAR |
| 2021-03-22 | 4 | Savara Inc (SVRA) | Purchase (P): 24,100 @ $2.07 | EDGAR |
| 2021-02-23 | 4 | Savara Inc (SVRA) | Purchase (P): 28,700 @ $1.74 | EDGAR |
| 2020-12-17 | 4 | Savara Inc (SVRA) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2020-09-15 | 4 | Savara Inc (SVRA) | Option exercise (M): 650 @ $0 · Grant/award (A): 227,272 @ $0 · Option exercise (M): 650 (derivative) @ $0 · Grant/award (A): 898,639 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1573429 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs